Does Red Light Therapy Help with Myofascial Pain Syndrome? A Doctor-Backed Analysis

Quick Answer: Yes—red light therapy, clinically termed photobiomodulation (PBM), has demonstrated effectiveness in reducing pain and improving pressure pain thresholds in myofascial pain syndrome, particularly when combined with exercise. A 2022 systematic review of 944 patients found that PBM plus exercise produced a large effect size for pain reduction, while standalone PBM showed moderate benefits.

Understanding Myofascial Pain Syndrome

Myofascial pain syndrome (MPS) is a chronic musculoskeletal condition characterized by trigger points—sensitive, tight knots within muscle tissue and fascia that produce deep, aching pain. These trigger points can refer pain to distant areas, often manifesting as shoulder pain, tension headaches, or back pain.

Dr. Arya Mohabbat, a general internist at Mayo Clinic’s Fibromyalgia and Chronic Fatigue Clinic, explains the distinction: “Myofascial pain syndrome involves mainly muscular pain; whereas, fibromyalgia includes more widespread body pain, along with other symptoms, such as headaches, bowel problems, fatigue and mood changes”. The condition is typically diagnosed clinically through physical examination, as there are no definitive diagnostic tests available.

What Is Red Light Therapy?

Red light therapy—also called low-level laser therapy (LLLT) or photobiomodulation therapy (PBMT)—uses red or near-infrared light to stimulate cellular processes. Research indicates these wavelengths may act through mitochondrial photoacceptors, modulating ATP production, reactive oxygen species, nitric oxide signaling, and inflammatory pathways .

The therapy is non-invasive, generally well-tolerated, and targets tissue repair and microcirculation—therapeutic goals directly relevant to MPS pathophysiology. Clinical evidence supports potential benefit across several musculoskeletal conditions, including cervical myofascial pain, temporomandibular disorders, and tendinopathies.

The Clinical Evidence

Systematic Reviews and Meta-Analyses

Study	Population	Key Finding
Alayat et al., 2022 (Systematic Review/Meta-analysis)	944 patients with upper trapezius MPS	PBM alone: medium effect size (SMD -0.54); PBM + exercise: large effect size (SMD -0.80) for pain reduction
Sobral et al., 2021 (Systematic Review/Meta-analysis)	TMD patients with myofascial pain	Laser-treated groups showed superior pain improvement vs. control (mean difference 1.49)
Tehrani et al., 2022 (Systematic Review)	Myofascial neck pain syndrome	LLLT may reduce myofascial neck pain and related outcomes
Ailioaie et al., 2026 (Narrative Review)	Musculoskeletal pain conditions	Red/NIR LED-PBM shows clinical promise for cervical and myofascial pain

The 2022 meta-analysis by Alayat and colleagues is particularly instructive. Analyzing 17 studies with 944 total patients, researchers found that PBM alone produced a medium effect size for pain reduction, while PBM combined with exercise produced a large effect size. The authors concluded that “PBMT is an effective PT modality for reducing pain and increasing PPT in patients with MPS of the upper trapezius”.

Randomized Controlled Trials

A 2023 double-blind RCT compared red LED light therapy against low-level laser for temporomandibular myofascial pain. Sixty patients were divided into three groups: placebo, red LED light, and laser therapy. Both active treatment groups showed statistically significant pain improvement compared to placebo at visits 3 and 4, with no significant differences between LED and laser outcomes. The researchers noted that “biosafety and lower cost of the LED light device compared to the LASER should also be considered”.

How It Compares: Treatment Modalities for MPS

Treatment	Evidence Level	Mechanism	Considerations
Red Light Therapy (PBM)	Moderate (systematic reviews, RCTs)	Mitochondrial stimulation, reduced inflammation, improved microcirculation	Non-invasive; effects enhanced when combined with exercise
Low-Level Laser Therapy	Moderate (RCTs)	Similar photobiomodulation mechanisms	Higher cost than LED; some studies show slightly greater effect than LED
Trigger Point Injections	Established	Local anesthetic/steroid directly into trigger point	Invasive; Mayo Clinic lists as treatment option
Physical Therapy/Exercise	Strong	Stretching, strengthening, postural correction	Core treatment; PBM amplifies effects when combined
Massage Therapy	Moderate	Manual release of trigger points	Symptomatic relief; Mayo Clinic recommends as self-care

A 2024 comparative study found that while both red LED light and low-level laser reduced pain in TMJ dysfunction patients, laser therapy showed slightly higher effectiveness (53.7% vs. 47.02% VAS reduction; 72.21% vs. 62.34% trigger point reduction). However, the clinical significance of these differences remains debatable, and LED offers advantages in cost and accessibility.

Limitations and Considerations

The evidence base, while promising, has important limitations. The Alayat systematic review rated evidence quality as low to medium, noting that “low-quality studies with low to moderate quality of evidence limit the confidence in the effect estimate and recommend further high-quality studies for standardization of treatment protocols and irradiation parameters”.

The Ailioaie review similarly cautioned that “current evidence is limited by heterogeneous devices, incomplete dosimetry, variable comparators, and short follow-up”. Therapeutic response depends on multiple parameters including wavelength, irradiance, radiant exposure, treatment geometry, and target depth—factors that vary significantly across studies.

A 2025 triple-blind RCT added nuance, finding that PBM “effectively alleviated pain and improved jaw function in patients with MPDS, with outcomes comparable to conventional conservative care,” though the study also emphasized that placebo effects must be considered.

Practical Implications

For individuals considering red light therapy for myofascial pain:

Combine with exercise: The strongest evidence supports PBM as an adjunct to physical therapy, not as a standalone treatment.
Expect cumulative effects: Most studies employed multiple sessions (typically 2x weekly for 4 weeks) before significant improvements emerged .
Consider LED as a cost-effective option: While laser may have marginal advantages, LED devices offer comparable outcomes at lower cost.
Consult a healthcare provider: MPS diagnosis requires clinical evaluation to rule out other conditions .

Frequently Asked Questions

Is red light therapy FDA-cleared for myofascial pain?
The FDA has cleared various low-level laser and LED devices for musculoskeletal pain, though specific clearance depends on the device and indications.

How many sessions are needed?
Clinical protocols typically involve 4–10 sessions over 4 weeks, with 2 sessions per week being common .

Can red light therapy replace trigger point injections?
There is no evidence that PBM is superior to injections. Treatment selection should be individualized with a pain specialist.

Does insurance cover red light therapy for MPS?
Coverage varies. Many devices are available over-the-counter for home use, though clinical-grade devices used in medical settings may have different coverage policies.

Conclusion

The evidence supports red light therapy as a viable, non-invasive adjunctive treatment for myofascial pain syndrome. The most robust finding across systematic reviews is that PBM combined with exercise produces superior outcomes compared to either intervention alone. While questions remain about optimal dosing parameters and long-term durability, the safety profile and cost-effectiveness of LED-based devices make this a reasonable option to discuss with a healthcare provider.

For persistent muscle pain that does not improve with rest and self-care, Mayo Clinic advises making an appointment with a healthcare professional. Red light therapy may serve as part of a comprehensive treatment plan, but it is not a substitute for accurate diagnosis and appropriate medical care.